Has Sadaf Noor received payments from drug or device companies?

Yes. Drug and device makers reported $4,928 in general payments to Sadaf Noor across 261 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sadaf Noor did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sadaf Noor come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sadaf Noor

Psychiatry · Frisco, TXNPI 1194108555

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.4% of the total. 2025 is the largest year on record at $1,845, more than ten times the $53 reported in 2020.

$4,928in general payments, 2019–2025

Across 261 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Otsuka America Pharmaceutical, Inc.$705
Lundbeck LLC$406
Johnson & Johnson$358
Takeda Pharmaceuticals U.S.A., Inc.$326
Corium, LLC$225
plus $2K from 21 others

What the payments were for

Food & beverage$4,88099%
Education$481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	68	$1,250
Otsuka America Pharmaceutical, Inc.	40	$705
Lundbeck LLC	21	$406
Johnson & Johnson	14	$358
Takeda Pharmaceuticals U.S.A., Inc.	18	$326
Corium, LLC	17	$225
Tris Pharma Inc	10	$211
Axsome Therapeutics, Inc.	9	$176
Supernus Pharmaceuticals, Inc.	6	$166
Vanda Pharmaceuticals Inc.	7	$149
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	8	$136
Bausch Health US, LLC	6	$106
Neurocrine Biosciences, Inc.	4	$87
Teva Pharmaceuticals USA, Inc.	4	$82
Neos Therapeutics, LP	4	$76
E.r. Squibb & Sons, L.L.C.	3	$65
Sunovion Pharmaceuticals Inc.	4	$59
Neuronetics, Inc.	3	$58
Collegium Pharmaceutical, Inc.	3	$55
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$48
Vertical Pharmaceuticals, LLC	2	$35
Jazz Pharmaceuticals Inc.	2	$35
Alkermes, Inc.	2	$31
Noven Therapeutics, LLC	1	$23
Ironshore Pharmaceuticals Inc.	1	$22
Eisai Inc.	1	$21
Almatica Pharma LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$117

How this compares

$4,928 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Other psychiatry in Frisco

Rakesh JainLake Jackson$7.2M
Arvinder Pal WaliaAustin$2.5M
Suresh SureddiPlano$2.2M
Martin GuerreroEl Paso$2M
Marty BennettAddison$1.8M
Matthew BramsHouston$1.5M
Vikram MehraKaty$1.2M
Joel HolinerDallas$948K
Frank ChenHouston$941K
Alice MaoHouston$850K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →